- Home
- CSX vs MREO Comparison
CSX vs MREO Comparison
Compare CSX & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSX
- MREO
- Stock Information
- Founded
- CSX 1978
- MREO 2015
- Country
- CSX United States
- MREO United Kingdom
- Employees
- CSX N/A
- MREO N/A
- Industry
- CSX Railroads
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- CSX Industrials
- MREO Health Care
- Exchange
- CSX Nasdaq
- MREO Nasdaq
- Market Cap
- CSX N/A
- MREO 451.5M
- IPO Year
- CSX N/A
- MREO N/A
- Fundamental
- Price
- CSX $32.83
- MREO $3.16
- Analyst Decision
- CSX Buy
- MREO Strong Buy
- Analyst Count
- CSX 21
- MREO 6
- Target Price
- CSX $36.90
- MREO $7.83
- AVG Volume (30 Days)
- CSX 15.3M
- MREO 1.3M
- Earning Date
- CSX 01-23-2025
- MREO 03-26-2025
- Dividend Yield
- CSX 1.46%
- MREO N/A
- EPS Growth
- CSX N/A
- MREO N/A
- EPS
- CSX 1.79
- MREO N/A
- Revenue
- CSX $14,540,000,000.00
- MREO $1,000,000.00
- Revenue This Year
- CSX $4.04
- MREO N/A
- Revenue Next Year
- CSX $4.47
- MREO $54.47
- P/E Ratio
- CSX $18.41
- MREO N/A
- Revenue Growth
- CSX N/A
- MREO N/A
- 52 Week Low
- CSX $31.43
- MREO $2.53
- 52 Week High
- CSX $40.12
- MREO $5.02
- Technical
- Relative Strength Index (RSI)
- CSX 45.97
- MREO 48.76
- Support Level
- CSX $32.64
- MREO $2.85
- Resistance Level
- CSX $33.40
- MREO $3.06
- Average True Range (ATR)
- CSX 0.72
- MREO 0.18
- MACD
- CSX 0.05
- MREO 0.02
- Stochastic Oscillator
- CSX 27.06
- MREO 96.00
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).